147
edits
Changes
→Vaccine Failure
**The serum can then be injected into a different animal to confer passive immunisation
**The serum can then be injected into a different animal to confer passive immunisation
Examples of passive immunisation:
{| style="width:60%; height:200px" border="1" align=left
{| style="width:60%; height:200px" border="1" align=left
!INFECTION
!INFECTION
===Active immunisation===
===Active immunisation===
Active immunisation requires the administration of antigen so the patient develops thier own [[Immunoglobulins|antibodies]] to protect against disease. Suitable antigens include:
Active immunisation requires the administration of antigen so the patient develops their own antibodies to protect against disease. Suitable antigens include:
*Living organisms
*Living organisms
*Dead organisms
*Dead organisms
'''Advantages'''
'''Advantages'''
*Long duration of action; once [[Immunoglobulins|antibody]] is produced against the antigen, [[B cell differentiation#Memory cells|memory cells]] are formed which continue circulating in the body
*Long duration of action; once antibody is produced against the antigen, [[B cell differentiation#Memory cells|memory cells]] are formed which continue circulating in the body
'''Disadvantages'''
'''Disadvantages'''
*The host's immune system needs to evoke an immune response against the antigen which can take a few days
*The host's immune system needs to evoke an immune response against the antigen which can take a few days
*Can require two or more doses to be effective; the first dose initiates the '''priming''' reaction where [[Immunoglobulins|antibody]] production ceases after a few weeks, but the second and subsequent doses create [[B cell differentiation#Memory cells|memory cells]] which remain in the circulation for a much longer period of time
*Can require two or more doses to be effective; the first dose initiates the '''priming''' reaction where antibody production ceases after a few weeks, but the second and subsequent doses create memory cells which remain in the circulation for a much longer period of time.
==Vaccine Antigens==
==Vaccine Antigens==
LA vaccines produce a superior response to disease than using killed organisms as the dose of antigen is larger and more sustained, and the response takes place at the site of natural infection, producing a greater local response than with killed organism vaccines. Examples include:
LA vaccines produce a superior response to disease than using killed organisms as the dose of antigen is larger and more sustained, and the response takes place at the site of natural infection, producing a greater local response than with killed organism vaccines. Examples include:
*The current vaccine for Tuberculosis (called BCG) contains an attenuated form of a mycobacteria
*The current vaccine for tuberculosis (called BCG) contains an attenuated form of a mycobacteria
*Vaccines for Leishmaniasis
*Vaccines for leishmaniasis
*Vaccines for parainfluenza virus 3 of calves is developed to be temperature-sensitive so that it grows at 34 C in the upper respiratory tract but not at 38 C in the lungs
*Vaccines for parainfluenza virus 3 of calves is developed to be temperature-sensitive so that it grows at 34 C in the upper respiratory tract but not at 38 C in the lungs
==Adjuvants==
==Adjuvants==
Adjuvants are used with vaccines containing inactivated organisms which alone would only stimulate a weak immune response. Some adjuvants create a depot of antigen at the injection site allowing a steady flow of antigen into the afferent lymph, while others stimulate the immune system to amplify the adaptive immune response to antigens e.g. pathogen-associated molecular patterns (PAMPs). PAMP-like adjuvants assist naive [[Lymphocytes#T cells|T cell]] priming.
Adjuvants are used with vaccines containing inactivated organisms which alone would only stimulate a weak immune response. Some adjuvants create a depot of antigen at the injection site allowing a steady flow of antigen into the afferent lymph, while others stimulate the immune system to amplify the adaptive immune response to antigens e.g. pathogen-associated molecular patterns (PAMPs). PAMP-like adjuvants assist naive [[T cells|T cell]] priming.
Different subtypes of [[Lymphocytes#Helper CD4+|T helper cells]] are stimulated by different adjuvants, for example:
Different subtypes of [[T cell differentiation|T helper cells]] are stimulated by different adjuvants, for example:
*Aluminium salts generate bias [[T cell differentiation#TH2 Cells|T helper II]] responses for [[Immunoglobulins|'''antibody''']]-mediated immunity
*Aluminium salts generate bias [[T cell differentiation#TH2 Cells|T helper II]] responses for antibody-mediated immunity
*Killed mycobacteria generate IL-12 producing good '''cell'''-mediated immunity
*Killed mycobacteria generate IL-12 producing good '''cell'''-mediated immunity
The virus life cycle consists of an extracellular phase, a replicative intracellular phase and another extracellular phase spreading viral particles to other cells to begin the life cycle again
The virus life cycle consists of an extracellular phase, a replicative intracellular phase and another extracellular phase spreading viral particles to other cells to begin the life cycle again
Immunity for the extracellular phase requires neutralising [[Immunoglobulins|'''antibody''']]:
Immunity for the extracellular phase requires neutralising [[Immunoglobulins - Overview|'''antibody''']]:
*[[Lymphocytes#B Cells|B cells]] needed
*[[B cells]] needed
*[[T cell differentiation#TH2 Cells|T helper type II cells]] needed (for the [[Major Histocompatability Complexes#MHC II|MHC class II pathway]])
*[[T cell differentiation#TH2 Cells|T helper type II cells]] needed (for the [[Major Histocompatability Complexes#MHC II|MHC class II pathway]])
*Live, killed and subunit vaccines can be used
*Live, killed and subunit vaccines can be used
Immunity for the intracellular phase requires [[Lymphocytes#Cytotoxic CD8+|'''CD8+ cytotoxic T cells''']] and uses the [[Major Histocompatability Complexes#MHC I|MHC class I pathway]].
Immunity for the intracellular phase requires [[T_cells#Cytotoxic_CD8.2B|CD8+ cytotoxic T lymphocytes (CTL)]] and uses the [[Major Histocompatability Complexes#MHC I|MHC class I pathway]].
*Only live vaccine can be used to get into cells (entering via the endogenous pathway)
*Only live vaccine can be used to get into cells (entering via the endogenous pathway)
===Immunity to Bacterial Infection===
===Immunity to Bacterial Infection===
*Extracellular bacterial infection needs [[Immunoglobulins|'''antibody''']] production for [[Complement#Opsonisation|opsonisation]] and to activate the [[Complement|complement pathways]]
*Extracellular bacterial infection needs antibody production for [[Complement#Opsonisation|opsonisation]] and to activate the [[Complement|complement pathways]]
*[[Lymphocytes#B Cells|B cells]] are needed
*[[B cells]] are needed
*[[T cell differentiation#TH2 Cells|T helper type II cells]] are needed
*[[T cell differentiation#TH2 Cells|T helper type II cells]] are needed
[[Image:Colostrum Intake.jpg|right|thumb|200px|Colostrum Intake - Copyright Prof Dirk Werling DrMedVet PhD MRCVS]]
[[Image:Colostrum Intake.jpg|right|thumb|200px|Colostrum Intake - Copyright Prof Dirk Werling DrMedVet PhD MRCVS]]
[[Image:Vaccinating puppies with Parvo.jpg|right|thumb|200px|Response to vaccination against canine parvovirus depending on antibody titre of puppies - Copyright Prof Dirk Werling DrMedVet PhD MRCVS]]
[[Image:Vaccinating puppies with Parvo.jpg|right|thumb|200px|Response to vaccination against canine parvovirus depending on antibody titre of puppies - Copyright Prof Dirk Werling DrMedVet PhD MRCVS]]
*Breeding females can be vaccinated so that immunity is passively transfered to their offspring via the [[Materno-Fetal Immunity - Introduction#Passive transfer via colostrum|colostrum]] - this protects neonates for the first 8-12 weeks of life.
*Breeding females can be vaccinated so that immunity is passively transferred to their offspring via the [[Materno-Fetal Immunity - Introduction#Passive transfer via colostrum|colostrum]] - this protects neonates for the first 8-12 weeks of life.
*Vaccination of young animals should be when the natural passive immunity decreases below the threshold for providing protection. Active immunity should then be stimulated so that the animal has sustained protection. If vaccination is given too early, the natural immunity can interfere with immunisation by binding and neutralising the vaccine antigens.
*Vaccination of young animals should be when the natural passive immunity decreases below the threshold for providing protection. Active immunity should then be stimulated so that the animal has sustained protection. If vaccination is given too early, the natural immunity can interfere with immunisation by binding and neutralising the vaccine antigens.
'''When to Vaccinate'''
'''When to Vaccinate'''
Puppies are usually first vaccinated between 6 to 8 weeks of age; a second vaccination is given 2 weeks later. Adult dogs need booster vaccination regularly (depending on the specific vaccination and the recommendations of the vaccine manufacturer).
Puppies are usually first vaccinated between 6 to 8 weeks of age; a second vaccination is given 3-4 weeks later. Younger puppies (less than 16 weeks old) may require the third booster 3-4 weeks later, making the vaccination schedule to end between 14 to 16 weeks old. Adult dogs need booster vaccination regularly (depending on the specific vaccination and the recommendations of the vaccine manufacturer).
===Cat Vaccinations===
===Cat Vaccinations===
'''When to Vaccinate'''
'''When to Vaccinate'''
Kittens are usually vaccinated around 9 weeks old and a second vaccination is given 3 weeks later. Adult cats need booster vaccination regularly (depending on the specific vaccinationand the vaccine manufacturers recommendations).
Kittens are usually vaccinated around 9 weeks old and a second vaccination is given 3 weeks later. Adult cats need booster vaccination regularly (depending on the specific vaccination and the vaccine manufacturers recommendations).
===Rabbit Vaccinations===
===Rabbit Vaccinations===
'''When to Vaccinate'''
'''When to Vaccinate'''
Rabbits can be vaccinated against [[Myxomatosis]] from 6 weeks of age and VHD from 2½ to 3 months of age. Booster vaccinations are given every 12 months. In areas at high risk of myxomatosis, it is recommended to give myxomatosis boosters at six-monthly intervals. Some myxomatosis vaccines need to given [[Vaccinations_for_Rabbits#Myxomatosis_Vaccination|partially intradermally]].
Rabbits can be vaccinated against [[Myxomatosis|myxomatosis]] from 6 weeks of age and VHD from 2½ to 3 months of age. Booster vaccinations are given every 12 months. In areas at high risk of myxomatosis, it is recommended to give myxomatosis boosters at six-monthly intervals. Some myxomatosis vaccines need to given [[Vaccinations_for_Rabbits#Myxomatosis_Vaccination|partially intradermally]].
==Vaccine Failure==
==Vaccine Failure==
Failures do occur and should be reported on the VMD [http://www.vmd.gov.uk/ 'yellow form' MLA252A]. Circumstances leading to vaccine failures include:
Failures do occur and should be reported on the VMD [http://www.vmd.gov.uk/ 'yellow form' MLA252A] if the events occur in the United Kingdom. Vaccine failures in other European Union (EU) Member States, Norway, Iceland and Liechtenstein should be reported to the relevant competent authority where the event occurred using the [http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000176.jsp&mid=WC0b01ac058002ddcb/ EU reporting forms for veterinarians] which are available in each EU language on the [http://www.ema.europa.eu/ European Medicines Agency] website. Circumstances leading to vaccine failures include:
*Recipient is already infected with the virus or is immunosuppressed and unable to mount an immune response.
*Recipient is already infected with the virus or is immunosuppressed and unable to mount an immune response.
*Break down of the '''cold-chain''' during transport (incorrect storage of vaccines requiring refridgeration)
*Break down of the '''cold-chain''' during transport (incorrect storage of vaccines requiring refrigeration)
*Improper administration (e.g.myxomatosis vaccine)
*Improper administration (e.g.myxomatosis vaccine)
*Accindental mixing of inactivated and live vaccines in the same syringe
*Accidental mixing of inactivated and live vaccines in the same syringe
*Recipient has maternal antibody to the vaccine
*Recipient has maternal antibody to the vaccine
*Vaccine is damaged during manufacture
*Vaccine is damaged during manufacture
==Test Yourself==
{{Learning
|flashcards = [[Vaccination Flashcards|Vaccination Flashcards]]
|full text =[http://www.cabi.org/cabdirect/FullTextPDF/2009/20093258316.pdf '''Factors influencing vaccine efficacy - a general review.''' Rashid, A.; Rasheed, K.; Akhtar, M.; Pakistan Agricultural Scientists Forum, Lahore, Pakistan, JAPS, Journal of Animal and Plant Sciences, 2009, 19, 1, pp 22-25, 18 ref.]
[http://www.cabi.org/cabdirect/FullTextPDF/2009/20093115229.pdf ''' Establishing vaccine protocols - focus on client communication.''' Datz, C.; The North American Veterinary Conference, Gainesville, USA, Small animal and exotics. Proceedings of the North American Veterinary Conference, Orlando, Florida, USA, 17-21 January, 2009, 2009, pp 608-611]
[[File:CABI logo.jpg|left|90px]]
[http://www.cabi.org/cabdirect/FullTextPDF/2009/20093115232.pdf '''Feline lifestyle vaccination protocols.''' Lappin, M. R.; The North American Veterinary Conference, Gainesville, USA, Small animal and exotics. Proceedings of the North American Veterinary Conference, Orlando, Florida, USA, 17-21 January, 2009, 2009, pp 621-624, 18 ref.]
[http://www.cabi.org/cabdirect/FullTextPDF/2007/20073166574.pdf '''Immunological basis of vaccination.''' Lunn, D. P.; The North American Veterinary Conference, Gainesville, USA, Large animal. Proceedings of the North American Veterinary Conference, Volume 21, Orlando, Florida, USA, 2007, 2007, pp 135-137]
[http://www.cabi.org/cabdirect/FullTextPDF/2009/20093258316.pdf '''Factors influencing vaccine efficacy - a general review.''' Rashid, A.; Rasheed, K.; Akhtar, M.; Pakistan Agricultural Scientists Forum, Lahore, Pakistan, JAPS, Journal of Animal and Plant Sciences, 2009, 19, 1, pp 22-25, 18 ref. - '''Full Text Article''']
[http://www.cabi.org/cabdirect/FullTextPDF/2009/20093115229.pdf ''' Establishing vaccine protocols - focus on client communication.''' Datz, C.; The North American Veterinary Conference, Gainesville, USA, Small animal and exotics. Proceedings of the North American Veterinary Conference, Orlando, Florida, USA, 17-21 January, 2009, 2009, pp 608-611 - '''Full Text Article''']
[http://www.cabi.org/cabdirect/FullTextPDF/2007/20073166575.pdf '''Equine vaccines: what works, what doesn't?''' Lunn, D. P.; The North American Veterinary Conference, Gainesville, USA, Large animal. Proceedings of the North American Veterinary Conference, Volume 21, Orlando, Florida, USA, 2007, 2007, pp 138-140]
[http://www.cabi.org/cabdirect/FullTextPDF/2009/20093115232.pdf '''Feline lifestyle vaccination protocols.''' Lappin, M. R.; The North American Veterinary Conference, Gainesville, USA, Small animal and exotics. Proceedings of the North American Veterinary Conference, Orlando, Florida, USA, 17-21 January, 2009, 2009, pp 621-624, 18 ref. - '''Full Text Article''']
|Vetstream = [https://www.vetstream.com/canis/Content/Freeform/fre00859.asp Vaccination Protocol]
}}
==Links==
==Links==
:[[:Category:Viral Organisms|Viruses A to Z]]
:[[:Category:Bacterial Organisms|Bacteria A to Z]]
[[:Category:Viral Organisms|Viruses A to Z]]
[[:Category:Bacterial Organisms|Bacterial A to Z]]
==References==
==References==
'''Textbooks'''
'''Textbooks'''
*Ivan Roitt: '''Essential Immunology,''' Ninth edition
*Ivan Roitt: '''Essential Immunology,''' Ninth edition
'''Lecture Notes'''
'''Lecture Notes'''
*Dr Brian Catchpole BVetMed PhD MRCVS
*Dr Brian Catchpole BVetMed PhD MRCVS
*Dr Peter H Russell BVSc MSc PhD MRCVS FRCPath
*Dr Peter H Russell BVSc MSc PhD MRCVS FRCPath
<br><br>
{{Jim Bee 2007}}
[[Category:Immunology]]
[[Category:Immunology]]